HIV: is a vaccine the answer?

Hum Vaccin Immunother. 2014;10(1):238-40. doi: 10.4161/hv.26243. Epub 2013 Sep 4.

Abstract

Getting to zero: zero new HIV infections, zero deaths from AIDS-related illness, zero discrimination is the theme of World AIDS Day 2012. Given the spread of the epidemic today, getting to zero may sound difficult, but significant progress is underway. The total annual loss for the entire country due to HIV is 7% of GDP, which exceeds India's annual health expenditure in 2004. The additional loss due to loss of labor income and increased medical expenditure as measured by the external transfers, account for 5% of the country's health expenditure and 0.23% of GDP. Given that the HIV incidence rate is only 0.27% in India, these losses are quite staggering. Despite the remarkable achievements in development of anti-retroviral therapies against HIV and the recent advances in new prevention technologies, the rate of new HIV infections continue to outpace efforts on HIV prevention and control. Thus, the development of a safe and effective vaccine for prevention and control of AIDS remains a global public health priority and the greatest opportunity to eventually end the AIDS pandemic.

Keywords: HIV; immunity; research; vaccine; virus.

Publication types

  • Review

MeSH terms

  • AIDS Vaccines / immunology*
  • AIDS Vaccines / isolation & purification*
  • HIV Infections / economics
  • HIV Infections / epidemiology*
  • HIV Infections / immunology
  • HIV Infections / prevention & control*
  • Health Care Costs
  • Humans
  • India / epidemiology
  • Vaccination / methods*

Substances

  • AIDS Vaccines